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EDITORIAL
Translational Pathology and the Understanding of Disease
Celebration of 125 years
It is the 125th anniversary of the inception of The Journal
of Pathology and Bacteriology. Although founded in
1892, the first issue of the Journal was published with
a cover date of 1893 and we are therefore taking the
liberty of celebrating this event over two years! Readers
may have noticed that our recent paper issues have
featured the banner ‘Publishing since 1892: 125 years
of research excellence’; and this editorial is timed to
coincide with the mid-point of the anniversary period.
The Journal was originally published as The Journal
of Pathology and Bacteriology and this broad scope
endured until 1969, when microbiology content was
moved to The Journal of Medical Microbiology [1].
Further focus was provided by the introduction in 2001
of our current strapline ‘Understanding Disease’, which
is aligned to the mission of the Pathological Society [2],
‘Understanding Disease – Guiding Therapy’. The latter
is also the focus of our companion journal The Journal
of Pathology: Clinical Research [3].
With recent technological advances, in particu-
lar massively parallel sequencing and other high
throughput technologies, it is timely to re-consider
how tissue-based studies inform our understanding of
disease. For example, massively parallel sequencing
analysis of human cancers and cancer models trans-
formed our understanding of the genetic and epigenetic
basis of human diseases, has identified numerous
genotypic-phenotypic correlations and pathognomonic
genetic alterations in rare tumour types, and is enabling
the potential of precision medicine to be realised. This
transformative effect has now been documented in
the context of clinical trials, where massively parallel
sequencing technologies have enabled investigators
to understand the molecular and mechanistic basis of
unexpected dramatic responses to specific therapeutic
agents, the so-called ‘extreme outliers’. Moreover, the
careful analysis of pathology samples in conjunction
with diligent use of massively parallel sequencing
methods has brought to the forefront of cancer research
the challenges posed by intra-tumour heterogeneity for
the diagnosis and genetic characterization of the reper-
toire of genetic and epigenetic alterations in human
cancers, and for the development and validation of
biomarkers. Undoubtedly, the unprecedented pace of
technological development for the molecular character-
ization of pathology specimens and the development of
robust computational biology approaches to interpret
the enormous amounts of data generated provide a
unique opportunity to further our understanding of the
pathophysiological and pathogenetic mechanisms of
human disease.
Annual Review Issue 2018 – Molecular Pathology
of Cancer
The publication of themed Annual Review Issues has
been a significant and highly successful feature of
The Journal of Pathology since 1999. To reflect the
focus of the journal on understanding disease, cou-
pled with recent advances in technologies applicable
to the investigation of disease mechanisms, the 2018
Annual Review Issue, Guest Edited by David Hunts-
man and Marc Ladanyi, will feature articles address-
ing the contribution of translational studies to new con-
cepts in, and site-specific understanding of, cancer. The
issue is scheduled for publication in April 2018 and
the articles will signpost the Journal’s interest in stud-
ies that address important questions in the pathobiology
of disease.
Call for Papers
With our focus on translational studies that improve
understanding of disease mechanisms and behaviour,
The Journal of Pathology is ideally placed to publish
your primary research that provides novel insights into
the genetic and epigenetic basis of human diseases,
including:
• the identification of novel genotypic-phenotypic asso-
ciations and pathognomonic genetic alterations;
• the characterization of patterns of genetic instability,
mutational and rearrangement signatures in human
cancers and their impact on the pathobiology of the
disease;
• intra-tumour genetic and epigenetic heterogeneity,
and approaches to address the challenges posed by
this biological phenomenon;
• detailed molecular analyses of mechanisms of
response and resistance to therapeutic agents identi-
fied by massively parallel sequencing.
Such submissions should report studies that address
important questions in the pathobiology of disease,
particularly those that use massively parallel sequenc-
ing technology. Manuscripts should ideally offer clin-
ically relevant findings and/or functional insights with
validation. Timely reviews and perspectives would also
be considered.
Correctly formatted manuscripts will be fast-tracked
and expertly peer-reviewed, aiming for a final decision
within 10 working days. We would anticipate that initial
online publication would occur within 7 days of accep-
tance. Once published, each article will be made free
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to view online for 6months, facilitating dissemination
within the community.
In your covering letter, please mention that the sub-
mission is a response to the “translational pathology and
precision medicine call”. Please note that any massively
parallel sequencing data included in themanuscript must
be made publicly available by the time of publication,
and full details of the analysis methods should be pro-
vided either in the main manuscript or as supplementary
methods.
We look forward to receiving your manuscript via
http://mc.manuscriptcentral.com/jpath
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